WIXLIB

As local governments deal with this economic growth, many arealso concerned with anti-corruption, anti-bribery and transparency. Local laws are being passed to address these issues inmany countries. Local associations are creating codes of ethicsand health care systems are becoming more vigilant. Thesedevelopments present challenges for pharmaceutical and medicaldevice companies to adapt, change and evolve faster to be able torespond with new internal processes and behaviors.ABOUT THE CONGRESS CO SPONSORS:CETIFARMA, the Council of Ethics and Transparency of Pharmaceutical Industry, is anautonomous and independent institution born in 2005 and it is part of the National Chamberof Pharmaceutical Industry (CANIFARMA). CETIFARMA aims to promote and maintain ethical conduct and transparentpractices for the benefit of society and the sustainability of the industry in Mexico. CETIFARMA has established a Codeof Ethics and Transparency in Pharmaceutical Industry, a Code of Good Promotional Practices and a Code for the Interaction with Patient Organizations.CANIFARMA, founded in 1946 under the Law of Chambers and Business Organizations, theNational Chamber of the Pharmaceutical Industry (CANIFARMA), is an autonomous institution ofpublic interest, in accordance with the provisions of that law and is an organ of consultation andcooperation of the State. Currently consisting of 187 companies, representing four specialties orbranches of production essential for health: Human use medicine, Veterinary use medicine, HealthAuxiliary Products and Reagents and diagnostic systems.The First Latin American Pharmaceutical and Medical DeviceCompliance Congress was held in São Paulo, Brazil in October of2012. The Second Latin American Pharmaceutical and MedicalDevice Compliance Congress moves to Mexico City.The Second Latin American Pharmaceutical and Medical DeviceCompliance Congress offers a rare opportunity for pharmaceuticaland medical device companies conducting business in Latin Americato hear from industry experts on cutting edge practical approachesto help manage these challenges in this fast growing region. TheCongress is sponsored by the Latin American Ethics and ComplianceNetwork, a voluntary group of pharmaceutical and medical devicecompliance professionals and legal counsel with regional oversightor responsibility across the Latin American region and co-sponsoredby a number of organizations listed here on the right.The National Bioethics Commission is a deconcentrated agency of the Secretariat of Health,with technical and operational autonomy, born in 1989. The Central object of the NationalBioethics Commission is to promote bioethical culture in the country, which involves establishingthat it is about boosting ethical development of the society as a whole, encouraging a thoughtfulawareness in both individuals and society towards uncertain situations that techno-scientificadvancements entail, as well as looking for a greater engagement in the context of a plural and respectful discussion,and regulations that look after the social benefit without damaging social groups that are in a vulnerable position.The International Society of Healthcare Ethics and Compliance Professionals (ETHICS)is a professional society established in 2012 currently comprised of around 50 members, all activein major pharma and medical device companies. ETHICS intends to become the reference professional society for ethics and compliance practitioners in the healthcare sector with the ultimategoal to contributing to the professional development of individuals and the success of ethics andcompliance organizations.The Congress will offer opportunities to hear from business leadersfrom the Industry, to identify top trends in this sector from Medicaland Patient Organizations, to benchmark best practices frommulti-national pharmaceutical and medical device corporations,to hear from several Latin American Pharma associations and learnabout the latest codes and laws. This is the must attend pharmaceutical and medical device compliance conference of the year.The National Academy of Medicine in Mexico, was created nearly 150 years ago and is theoldest medical association in Mexico. It congregates 600 physicians and healthcare professionalsof all specialties and branches of medicine, including both national and foreign members. It isinvolved in the promotion of the study, research and continuous education in all fields of medicine,analyzing and disseminating knowledge and guiding criteria among healthcare professionals. Itis the most renowned medical association, and as such it has the moral standing to endorse issuesrelated to ethics and transparency.WHO SHOULD ATTEND:Pharmaceutical ManufacturersGeneric PharmaceuticalManufacturersMedical Device ManufacturersSite Management OrganizationsClinical Research OrganizationsManagement CompaniesWholesale, Retail, Mail Orderand Internet PharmaciesHealth Care Regulatorsand Policy MakersPharmaceutical and Health CareExecutives and Board MembersRegulatory and ComplianceProfessionalsMedical DirectorsPhysiciansPharmacistsFood and Drug Law AttorneysHealth Care Attorneysand In-house CounselCompliance OfficersPrivacy OfficersEthics Officers and CorporateSocial Responsibility PersonnelPharmaceutical ConsultantsInvestment BankersVenture CapitalistsHealth Services Researchersand AcademicsAuditorsPromotion Signatories/ApproversRisk Management PersonnelEXHIBIT AND SPONSORSHIP OPPORTUNITIES: Takeadvantage of this unique opportunity to expand your reach! The Congressis attended by highly influential and experienced professionals. Sponsorship offers you strategic positioning as an industry leader. For moreinformation call 206-673-4815 or email exhibits@hcconferences.com.2ABOUT THE CONGRESS SPONSOR:The Latin American Ethics and Compliance Network isan ad hoc, voluntary group of Latin American pharmaceutical, medical device and other life sciences companycompliance professionals and legal counsel with regional oversight or responsibility across the Latin American region who meet quarterly to discuss legal and compliance issues and best practices trying to raise ethical standards.The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceuticalmanufacturers. The PCF was founded in early-1999 by compliance professionals from thepharmaceutical industry to promote effective corporate compliance programs.PARTICIPATIONOPTIONSTRADITIONAL ONSITE ATTENDANCESimply register, travel to the conference cityand attend in person.PROS:subject matter immersion; professionalnetworking opportunities; faculty interaction.LIVE AND ARCHIVED INTERNET ATTENDANCEWatch the conference in livestreaming video over the Internetand at your convenience at anytime 24/7 for six months following the event.The archived conferenceincludes speaker videos andcoordinated PowerPointpresentations.At your office . . .PROS:Live digital feed and 24/7 Internet access for the nextsix months; accessible inthe office, at home or anywhereworldwide with Internet access;avoid travel expense and hassle;no time away from the office.Onsite. . . or homeCOVER PHOTO: iStock 2013 TorresignerTHE SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESSLatin America is one of the fastest growing economic regionsin the world. This has made Latin America one of the hottestmarkets for pharmaceutical and medical device sectorgrowth. Multi-national corporations are seeing near double digitgrowth in several countries and local companies are thriving inmost of the region.

TUESDAY, JULY 29, 20144:30 pmLatin American Transparency Concerns and Expectationsfrom the Pharmaceutical IndustryLATIN AMERICAN PHARMA/DEVICE COMPLIANCECONGRESS DAY I: OPENING PLENARY SESSION1:00 pmAlma Rocio Balcazar Romero, Esq., Representative, TransparencyInternational; Independent Consultant on Governance, Compliance andCorruption Risks, Bogotá, ColombiaWelcomeSharing a Local Experience in a Latin American Country— Transparency International, Mexican ChapterCarlos Campillo Serrano, MD, President, Council of Ethics andTransparency of the Pharmaceutical Industry (CETIFARMA), Mexico City, MexicoEduardo Bohórquez, Executive Director, Transparencia Mexicana,Mexico Chapter of Transparency International; Executive Director, EstePaís, Mexico City, MexicoImelda Álvarez, Integrity and Compliance Head for Latin America andCanada, Novartis Corporativo, S.A. de C.V., Mexico City, Mexico (Co-chair)1:10 pmLatin American Pharma/DeviceCongress Vision and OverviewImelda Álvarez, Integrity and Compliance Head for Latin America andCanada, Novartis Corporativo, S.A. de C.V., Mexico City, Mexico (Co-chair)Felipe Coronel, Esq., Chief Compliance Officer, Regional Head Office,Grünenthal Latin America, Panama City, Panama (Co-chair)Clivetty Martinez, PhD, Regional Vice President, Latin America Officeof Healthcare Compliance and Privacy, Johnson & Johnson International,Inc.; Chair, Latin American Ethics and Compliance Network, Miami, FL, USA(Co-chair)Ted Acosta, Esq., Principal, EY; Former Senior Counsel, Office ofthe Inspector General, United States Department of Health and HumanServices, New York, NY, USA and Paris, France (Moderator)5:15 pmGlobal Code Update RoundtableLatin American CodesEsther M. Flesch, Esq., Partner, Trench, Rossi e Watanabe,and Baker & McKenzie, São Paulo, BrazilIFPMA CodeTamara Music, Manager, Influenza Vaccines and Code Compliance,IFPMA, Geneva, SwitzerlandEFPIA CodeJose F. Zamarriego Izquierdo, Director Unidad de SupervisionDeontologica, FARMAINDUSTRIA, Madrid, Spain1:40 pmLATAM Compliance and Ethics —Perspectives from the C-suiteÓscar Ferenczi, Senior Vice President, Latin America, Grünenthal;Former Head Latin America, Sandoz; Former Vice President and GeneralManager Brazil and Former General Manager Chile, Peru, and Ecuador,Merck Sharp & Dohme, Miami, FL, USAPhRMA CodeKeith M. Korenchuk, JD, MPH, Partner, Arnold & Porter LLP,Washington, DC, USAAdvaMed/EUCOMED CodesRodrigo Salles Medina, JD, LLM, Legal Director, Latin America,Medtronic Inc, Miami, FL, USAAntonio Ferreira, International Vice President, Janssen Latin America,part of Janssen Pharmaceutical Companies of Johnson & Johnson;Chairman, Johnson & Johnson Latin American Contribution Committee(LACC); Board Member, Council of the Americas, Miami, FL, USAModeratorRussell Williams, President, Rx&D Canada; Chair, IFPMA CodeCompliance Network; Former Member, National Assembly of Quebec,Ottawa, CanadaGavin French, Vice President and General Manager, Latin America,Edwards Lifesciences, Sao Paulo, BrazilCarlos D. Garcia, MBA, President, Latin America and Canada,Novartis Latin America Services, Inc., Miami, FL, USATransparency International Keynote6:30 pmMiguel Salazar Hernandez, President and Country Manager, Mexico,Central America and Dominican Republic, Boehringer Ingelheim MexicoS.A. de C.V., Mexico City, MexicoADJOURNMENT AND NETWORKING RECEPTIONREGISTRATION DISCOUNTS AVAILABLE TO ASSOCIATION MEMBERS:t Latin American Ethicst CANIFARMAand Compliance Network t International Society(LatAm E&CN)of Healthcare Ethicsand Compliancet CETIFARMAProfessionals (ethics)Martin Mercer, Vice President, Latin America, Astellas Pharma;Former President, International Region, Valeant PharmaceuticalsInternational, Inc.; Former Vice President North Andes Zone,GlaxoSmithKline, Northbrook, IL, USAt Pharmaceutical ComplianceForum (PCF)t International Federation ofPharmaceutical Manufacturers& Associations (IFPMA)3:00 pmBreak3:30 pmEstablishing the ConsensusFramework for Ethical Collaboration:Patients, HCPs and IndustryJoanna Groves, Chief Executive Officer, International Alliance ofPatients’ Organizations (IAPO), London, UKOtmar Kloiber, MD, PhD, Secretary General, World Medical Association,Ferney-Voltaire, FranceRussell Williams, President, Rx&D Canada; Chair, IFPMA CodeCompliance Network; Former Member, National Assembly of Quebec,Ottawa, Canada (Moderator)Wikimedia Commons 2006 RosemaniaImelda Álvarez, Integrity and Compliance Head for Latin America andCanada, Novartis Corporativo, S.A. de C.V., Mexico City, Mexico (Moderator)3

WEDNESDAY, JULY 30, 20147:30 am11:30 amRegistration Commencest ,FZ 5SFOET JO (MPCBM 5SBOTQBSFODZ t &YUSBUFSSJUPSJBM *NQBDU PG 64 BOE &VSPQFBO Requirements on Latin American Operationst .BOBHJOH %BUB 1SJWBDZ BOE 1IZTJDJBO POTFOUt 1PUFOUJBM %FWFMPQNFOUT JO -BUJO "NFSJDBDAY II: MORNING PLENARY SESSION8:30 am8:45 amHow the US Sunshine Act and GlobalTransparency Trends will Impact Latin AmericaWelcome and OverviewClivetty Martinez, PhD, Regional Vice President, Latin America Officeof Healthcare Compliance and Privacy, Johnson & Johnson International,Inc.; Chair, Latin American Ethics and Compliance Network, Miami, FL, USA(Co-chair)Cecilia Abe, MBA, LATAM Regional Compliance Officer, Sanofi-Aventis;Former Senior Compliance Lead for LATAM, AstraZeneca Pharmaceuticals,Miami, FL, USALATAM Pharmaceutical Association ExecutiveRoundtableSandra Gonzalez, Esq., Associate, Porzio, Bromberg & Newman;Manager of Regulatory and Compliance Services, Porzio Life Sciences, LLC,Morristown, NJ, USADr. Alfredo Héctor Ahuad, Medical Manager, Cámara Argentina deEspecialidades Medicinales, Buenos Aires, ArgentinaLouis Ramos, Esq., Lead Compliance Counsel, Latin America,International R&D and Manufacturing, Pfizer Inc.; Former AssistantUnited States Attorney, United States Attorney’s Office for the District ofColumbia, Washington, DC, USARafael Gual Cosío, CH.E., General Director, National Chamber ofPharmaceutical Industry (CANIFARMA), Mexico City, MexicoMaría José Delgado, General Director, Brazilian Research-basedPharmaceutical Manufacturers Association (InterFarma), Sao Paulo, BrazilD. Jeffrey Campbell, Esq., Principal, Porzio, Bromberg & Newman PC;President and Chief Executive Officer, Porzio Life Sciences, Morristown, NJ,USA (Moderator)12:15 pmNETWORKING LUNCHEONDr. Francisco de Paula Gómez, Executive President, Association ofPharmaceutical Research Laboratories (AFIDRO), Bogotá, ColombiaDr. Rodolfo Lambour, Executive Director, Central American Federationof Pharmaceutical Laboratories (FEDEFARMA), GuatemalaCarlos Campillo Serrano, MD, President, Council of Ethics andTransparency of the Pharmaceutical Industry (CETIFARMA), Mexico City,Mexico (Moderator)DAY II: AFTERNOON MINI SUMMITSMINI SUMMITS ROUND IMINI SUMMIT I: CORE COMPLIANCE COMPETENCIESTRAINING It 5IF #BTJDT PG B PNQMJBODF 1SPHSBN 5IF (MPCBM 4UBOEBSE for Effective Programst 5IF 3PMF PG 7BMVFT #BTFE &UIJDT JO B PNQMJBODF 1SPHSBN9:45 amNew Business Models and New ComplianceChallengest 5IF 3PMF PG (PWFSOBODF %FDJTJPO .BLJOH BOE &TDBMBUJPOPaul Curtain, Esq. (Invited), Executive Director, InternationalCompliance, Forest Laboratories, New York, NY, USA1:30 pmIntroductions, Panel Discussion and Q&ASergio Abreu, JD, Regional Compliance Officer, LATAM, Merck KGaA, Montevideo, UruguayMichael R. Clarke, JD, Vice President Ethics and Compliance Americas, Actavis; Former VicePresident and Compliance Officer, Biomet Spine and Bone Healing Technologies; Former VicePresident, Chief Ethics and Compliance Officer, University of Medicine and Dentistry of NewJersey, Morristown, NJ, USAKeith M. Korenchuk, JD, MPH, Partner, Arnold & Porter LLP, Washington, DC, USA (Moderator)César Lara, Director, Pharmaceutical and Life Sciences Advisory, PwC,Mexico City, MexicoJonathon Kellerman, Principal, Pharmaceutical and Life SciencesAdvisory, PwC, Florham Park, NJ, USA (Moderator)10:15 amBreak10:45 amLATAM and Global Anticorruption UpdateMichael R. Clarke, Esq., Vice President, Ethics and Compliance Americas,Actavis; Former Vice President and Compliance Officer, Biomet Spineand Bone Healing Technologies; Former Vice President, Chief Ethics andCompliance Officer, University of Medicine and Dentistry of New Jersey,Morristown, NJ, USARodrigo Salles Medina, JD, LLM, Legal Director - Latin America,Medtronic Inc. Miami, FL, USAJoseph B. Tompkins, Jr., Partner, Sidley Austin LLP; Former DeputyChief of the Fraud Section, Criminal Division, United States Department ofJustice, Washington, DC, USATed Acosta, Esq., Principal, EY; Former Senior Counsel, Office ofthe Inspector General, United States Department of Health and HumanServices, New York, NY, USA and Paris, France (Moderator)4t 5IF 3PMFT BOE 3FTQPOTJCJMJUJFT PG UIF PNQMJBODF 0óDFS2:45 pmTransition BreakMINI SUMMIT II: MERCOSUR REGION (ARGENTINA,BRAZIL, PARAGUAY, URUGUAY, VENEZUELA AND BOLIVIA)COMPLIANCE UPDATE1:30 pmIntroductions, Panel Discussion and Q&ASergio Abreu, JD, Regional Compliance Officer, LATAM, Merck KGaA, Montevideo, UruguayVanina Caniza, JD, LLM, Partner, Baker & McKenzie, Buenos Aires, ArgentinaFernando M. Caleiro Palma, Esq., Executive Director, Corporate Compliance, Assurance– FIDS, EY; Executive, Instituto dos Advogados de São Paulo (IASP) and Fundação Instituto deAdministração, Business School (FIA); Former Divisional Compliance Officer, Americas, Stryker,São Paulo, BrazilEsther M. Flesch, Esq., Partner, Trench, Rossi e Watanabe and Baker & McKenzie,São Paulo, Brazil (Moderator)2:45 pmTransition Break

MINI SUMMIT III: NORTHERN LATAM, CENTRAL AMERICAAND CARIBBEAN COMPLIANCE UPDATE1:30 pmIntroductions, Panel Discussion and Q&ACecilia Abe, MBA, LATAM Regional Compliance Officer, Sanofi-Aventis; Former SeniorCompliance Lead for LATAM, AstraZeneca Pharmaceuticals, Miami, FL, USAJonathan Edward Adams, JD, MBA, Partner, Baker & McKenzie, Mexico City, MexicoFelipe Coronel, Esq., Chief Compliance Officer, Regional Head Office, Grünenthal LatinAmerica, Panama City, PanamaClaudia Hernández Loustalot Laclette, MA, Pharma and Country Compliance HeadMexico, Novartis Corporativo, S.A. de C.V.; Former Compliance and Ethics Director, Bristol-MyersSquibb; Former Compliance Manager, Eli Lilly, Mexico, City, MexicoKarla Guillén, Regional Lead Officer, Pharma Latin America, Health Care Compliance andPrivacy, Johnson & Johnson, Mexico City, Mexico (Moderator)2:45 pmTransition BreakMINI SUMMIT IV: THE IMPACT OF INTERNATIONAL PHARMACODES ON CONGRESSES: OUTLOOK AND TRENDS1:30 pmIntroductions, Panel Discussion and Q&AJose F. Zamarriego Izquierdo, PhD, Director Unidad de Supervision Deontologica,FARMAINDUSTRIA, Madrid, SpainChristian-Claus Roth, Head of Congresses and Conventions, Novartis Pharma; Co-President,International Pharmaceutical Congress Advisory Association (IPCAA), Berne, Switzerland (Moderator)2:45 pmTransition BreakMINI SUMMIT V: DEBUNKING ANALYTICS: IMPLICATIONSOF DATA ON COMPLIANCE MONITORING1:30 pmIntroductions, Panel Discussion and Q&ABrian Riewerts, Principal, Global Governance, Risk and Compliance Leader, Pharmaceuticaland Life Sciences Advisory, PwC, Baltimore, MD, USADavid Wysocky, Principal, Pharmaceutical and Life Sciences Advisory, PwC,Florham Park, NJ, USA (Moderator)2:45 pmTransition BreakMINI SUMMITS ROUND IIMINI SUMMIT VI: CORE COMPLIANCE COMPETENCIESTRAINING IIt t t t t 5IF #BTJDT PG "OUJDPSSVQUJPO5IF #BTJDT PG %JTDMPTVSF BOE 5SBOTQBSFODZ5IF #BTJDT PG 1SJDJOH BOE 3FJNCVSTFNFOU 5FOEFSJOH BOE 1VCMJD 1SPDVSFNFOU5IF #BTJDT PG %BUB 1SPUFDUJPO3:00 pmIntroductions, Panel Discussion and Q&ASergio Abreu, JD, Regional Compliance Officer, LATAM, Merck KGaA, Montevideo, UruguayMichael R. Clarke, JD, Vice President Ethics and Compliance Americas, Actavis; FormerVice President and Compliance Officer, Biomet Spine and Bone Healing Technologies; FormerVice President, Chief Ethics and Compliance Officer, University of Medicine and Dentistry of NewJersey, Morristown, NJ, USAKeith M. Korenchuk, JD, MPH, Partner, Arnold & Porter LLP, Washington, DC, USA (Moderator)4:15 pmTransition BreakMINI SUMMIT VII: PUBLIC PROCUREMENT AND PHARMAPRICING UPDATE, INCLUDING GOVERNMENT TENDERS ANDREGULATORY (REGISTRATION PROCESS)3:00 pmIntroductions, Panel Discussion and Q&APatricio Marquez Macias, Esq., General Counsel, Covidien, Mexico City, MexicoPatricia Miguel, Manager, Fraud Investigation and Dispute Service Practice, EY, São Paulo, BrazilFatima Wolff, Esq., Senior Compliance Counsel, Boston Scientific Corporation, Miami, FL, USAClaudia Navarro, Senior Director RA/QA, Covidien, Miami, FL, USA (Moderator)4:15 pmMINI SUMMIT VIII: INTERACTIONS WITH DISTRIBUTORS:BEST PRACTICES IN MONITORING COMPLIANCE OF THIRDPARTIES3:00 pmIntroductions, Panel Discussion and Q&AMaritza Escalante Andrade, Health Care Compliance Officer, Johnson & Johnson,Medical Device & Diagnostic, Mexico City, MexicoAndrés Cedrón, Esq., Legal Counsel and Director of Compliance, Americas, Stryker,Miramar, FL, USANancy A. Grygiel, JD, LLM, Vice President, Global Corporate Compliance, Allergan,Irvine, CA, USAIlana Shulman, Esq., Associate General Counsel, Legal and Compliance, Astellas US LLC,Northbrook, IL, USAGildas Durand, Senior Manager, EY, Miami, FL, USA (Moderator)4:15 pmTransition BreakMINI SUMMIT IX: ADVANCED ISSUES IN GLOBALTRANSPARENCY, DISCLOSURE AND AGGREGATE SPENDCOMPLIANCEt t t t t /VBODFE %FöOJUJPOT PG PWFSFE 3FDJQJFOUT BOE 0SHBOJ[BUJPOT3FQPSUJOH 3FTFBSDI BOE %FWFMPQNFOU 1BZNFOUT SPTT CPSEFS 4QFOE.BTUFS %BUB .BOBHFNFOU.BOBHJOH 7FOEPS "HSFFNFOUT BOE "HSFFNFOUT XJUI Covered Recipients3:00 pmIntroductions, Panel Discussion and Q&ACecilia Abe, MBA, LATAM Regional Compliance Officer, Sanofi-Aventis; Former SeniorCompliance Lead for LATAM, AstraZeneca Pharmaceuticals, Miami, FL, USASandra Gonzalez, Esq., Associate, Porzio, Bromberg & Newman; Manager of Regulatoryand Compliance Services, Porzio Life Sciences, LLC, Morristown, NJ, USALouis Ramos, Esq., Lead Compliance Counsel, Latin America, International R&D andManufacturing, Pfizer Inc.; Former Assistant United States Attorney, United States Attorney’sOffice for the District of Columbia, Washington, DC, USAD. Jeffrey Campbell, Esq., Principal, Porzio, Bromberg & Newman PC; President and ChiefExecutive Officer, Porzio Life Sciences, Morristown, NJ, USA (Moderator)4:15 pmTransition BreakMINI SUMMITS ROUND IIIMINI SUMMIT X: CORE COMPLIANCE COMPETENCIESTRAINING IIIt POEVDUJOH &òFDUJWF 5IJSE 1BSUZ %VF %JMJHFODFt %FWFMPQJOH &òFDUJWF PNNFSDJBM .FEJDBM #PVOEBSJFT JO *OUFSBDUJPOT XJUI ) 14t 5IF 3PMF PG "OBMZUJDT JO .POJUPSJOH BOE 1SPHSBN 0WFSTJHIUt #VJMEJOH &òFDUJWF 3FMBUJPOTIJQT XJUI UIF #VTJOFTT4:30 pmIntroductions, Panel Discussion and Q&ASergio Abreu, JD, Regional Compliance Officer, LATAM, Merck KGaA, Montevideo, UruguayMichael R. Clarke, JD, Vice President Ethics and Compliance Americas, Actavis; Former VicePresident and Compliance Officer, Biomet Spine and Bone Healing Technologies; Former VicePresident/Chief Ethics and Compliance Officer, University of Medicine and Dentistry of NewJersey, Morristown, NJ, USAKeith M. Korenchuk, JD, MPH, Partner, Arnold & Porter LLP, Washington, DC, USA(Moderator)5:45 pmAdjournmentTransition Break5

MINI SUMMIT XI: GLOBAL ANTI-BRIBERY MASTER CLASS8:45 am4:30 pmIntroductions, Panel Discussion and Q&AGary F. Giampetruzzi, Esq., Partner, Paul Hastings; Former Vice President, and AssistantGeneral Counsel and Head of Government Investigations, Pfizer Inc., New York, NY, USAIlana Shulman, Associate General Counsel, Legal and Compliance/Anti-corruption,Astellas US LLC, Northbrook, IL, USARyan Murphy, Partner, Pharmaceutical and Life Sciences Forensics, PwC, Chicago, IL, USA(Moderator)5:45 pmAdjournmentArthur Muratyan, Esq., Secretary General, International Society ofHealthCare Ethics and Compliance Professionals (ETHICS); Former VicePresident-Head of Legal Corporate, and Global Compliance Officer, Sanofi,Paris, France9:15 amMINI SUMMIT XII: NEW LATAM BUSINESS MODELSAND THEIR RELATED COMPLIANCE CHALLENGES(I.E., INTEGRATORS, BDPs, LICENSING, ETC.)4:30 pmIntroductions, Panel Discussion and Q&AFelipe Coronel, Esq., Chief Compliance Officer, Regional Head Office, Grünenthal LatinAmerica, Panama City, PanamaKarla Guillén, Regional Lead Officer, Pharma Latin America, Health Care Compliance andPrivacy, Johnson & Johnson, Mexico City, MexicoGildas Durand, Senior Manager, EY, Miami, FL, USA (Moderator)5:45 pm9:45 amEvaluation of the Worldwide EnforcementEnvironment for Pharma and Medical DevicesMichael K. Loucks, Esq., Partner, Skadden Arps LLP; Former ActingUnited States Attorney, US Attorney’s Office for the District of Massachusetts, Washington, DC, USAMaritza I. Munich, Esq., Chief Legal Officer, General Counsel andCorporate Secretary, Medical Card System, Inc.; Former General Counsel,Mexico & Central America, The Procter & Gamble Company; Former VicePresident & General Counsel - International, Wal-Mart Stores, Inc.,San Juan, Puerto Rico, USA10:15 amManaging the Gray Areas of ComplianceImelda Álvarez, Integrity and Compliance Head for Latin America andCanada, Novartis Corporativo, S.A. de C.V., Mexico City, MexicoMINI SUMMIT XIII: INVESTIGATIONS IN LATIN AMERICA5:45 pmAndrés Cedrón, Esq., Legal Counsel and Director of Compliance,Americas, Stryker, Miramar, FL, USAAdjournmentMauro Diaz, MBA, Compliance Officer, Latin America Pharmaceuticals,GlaxoSmithKline, Rio de Janeiro, BrazilTHURSDAY, JULY 31, 20147:30 amRegistration CommencesClivetty Martinez, PhD, Regional Vice President, Latin America Officeof Healthcare Compliance and Privacy, Johnson & Johnson International,Inc.; Chair, Latin American Ethics and Compliance Network, Miami, FL, USA(Moderator)DAY III: CLOSING PLENARY SESSION8:30 amWelcome and IntroductionsFelipe Coronel, Esq., Chief Compliance Officer, Regional Head Office,Grünenthal Latin America, Panama City, Panama (Co-chair)SAVE THEDATESHybridConferences& InternetEvents11:00 amTransition BreakFOURTH

Compliance Head for Latin America and Canada, Novartis Corporativo, S.A. de C.V., Mexico City, Mexico Felipe Coronel, Esq., Chief Compliance . The First Latin American Pharmaceutical and Medical Device Compliance Congress was held in São Paulo, Brazil in October of 2012. The Second Latin American Pharmaceutical and Medical